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Abstract
We show that a lack of guidance on how to choose the matching variables used in the Syn-
thetic Control (SC) estimator creates specification-searching opportunities in SC applications.
This undermines one of the potential advantages of the method, which is providing a trans-
parent way of choosing comparison units and, therefore, being less susceptible to specification
searching than alternative methods. To address this problem, we provide recommendations
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1 Introduction
The synthetic control (SC) method has been recently proposed in a series of seminal
papers by Abadie & Gardeazabal (2003), Abadie et al. (2010), and Abadie et al. (2015) as
an alternative method to estimate treatment effects in comparative case studies. Despite
being relatively new, this method has been used in a wide range of applications, including
the evaluation of the impact of terrorism, civil wars and political risk, natural resources
and disasters, international finance, education and research policy, health policy, economic
and trade liberalization, political reforms, labor, taxation, crime, social connections, and
local development.1 Athey & Imbens (2016) describe the SC method as arguably the most
important innovation in the evaluation literature in the last fifteen years.
Abadie et al. (2010) and Abadie et al. (2015) describe many advantages of the SC estimator
over techniques traditionally used in comparative studies. Among them, one important feature
of the SC method is that it provides a transparent way to choose comparison units. In the
SC method, a data-driven process is used to choose the weights that will build the weighted-
average of the controls’ outcomes that will represent the counterfactual for the treated unit.
Also, since the estimation of the SC weights does not require access to post-intervention
outcomes, researchers could decide on the study design without knowing how those decisions
would affect the conclusions of their studies. Taken together, these features potentially make
the SC method less susceptible to specification searching relative to alternative methods for
comparative case studies. This could be an important advantage of the SC method given the
growing debate about transparency in social science research (Miguel et al. (2014)).2
1SC has been used in the evaluation of the impact of terrorism, civil wars and political risk (Abadie &
Gardeazabal (2003), Bove et al. (2014), Li (2012), Montalvo (2011), Yu & Wang (2013)), natural resources
and disasters (Barone & Mocetti (2014), Cavallo et al. (2013), Coffman & Noy (2011), DuPont & Noy (2012),
Mideksa (2013), Sills et al. (2015), Smith (2015)), international finance (Jinjarak et al. (2013), Sanso-Navarro
(2011)), education and research policy (Belot & Vandenberghe (2014), Chan et al. (2014), Hinrichs (2012)),
health policy (Bauhoff (2014), Kreif et al. (2015)), economic and trade liberalization (Billmeier & Nannicini
(2013), Gathani et al. (2013), Hosny (2012)), political reforms (Billmeier & Nannicini (2009), Carrasco et al.
(2014), Dhungana (2011) Ribeiro et al. (2013)), labor (Bohn et al. (2014), Calderon (2014)), taxation (Kleven
et al. (2013), de Souza (2014)), crime (Pinotti (2012b), Pinotti (2012a),Saunders et al. (2014)), social connec-
tions (Acemoglu et al. (2013)), and local development (Ando (2015), Gobillon & Magnac (2016), Kirkpatrick
& Bennear (2014), Liu (2015), Severnini (2014)).
2 See Christensen & Miguel (2016) for an extensive literature review on research transparency and repro-
ducibility both in economics and other fields.
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An important limitation of the SC method, however, is that it does not provide clear
guidance on the choice of predictor variables that should be used to estimate the SC weights.3
Although Abadie et al. (2010) define vectors of linear combinations of pre-intervention out-
comes that could be used as predictors, there is no specific recommendation about which
linear combinations should be used. Such lack of guidance on how to choose the economic
predictors when implementing the synthetic control method translates into a wide variety of
different specifications in empirical applications of this method. For example, some applied
papers use all pre-treatment outcome lags as economic predictors, other papers select a subset
of the pre-treatment outcome lags as economic predictors, while other papers use the mean
of all pre-treatment outcome lags and other covariates as economic predictors.4 If different
specifications result in widely different choices of the synthetic control unit, then a researcher
would have relevant opportunities to select “statistically significant” specifications even when
there is no effect. Since a researcher would usually not be able to commit to a particular
specification before knowing how these decisions would affect the conclusion of her study, this
flexibility may undermine one of the main advantages of the SC method.5
In this paper, we evaluate the extent to which this variety of options in the synthetic control
method creates opportunities for specification searching considering only one particular step
of the method: the choice of which pre-treatment outcome values to include in the estimation
of the SC weights.6 Using Monte Carlo (MC) simulations and placebo simulations with
3To the best of our knowledge, Dube & Zipperer (2015) and Kaul et al. (2015) are the only other authors to
point out that there is little explicit guidance in the SC literature to determine the choice of predictors. However,
they do not explore the implications of such lack of specific guidance on the possibilities for specification
searching in SC applications.
4For example, Abadie & Gardeazabal (2003), Abadie et al. (2015) and Kleven et al. (2013) use the mean of
all pre-treatment outcome values and other covariates as predictors; Billmeier & Nannicini (2013), Bohn et al.
(2014), Gobillon & Magnac (2016), Hinrichs (2012) use all the pre-treatment outcome values; Smith (2015)
selects 4 out of 10 pre-treatment periods; Abadie et al. (2010) select 3 out of 19 pre-treatment periods; and
Montalvo (2011) uses only the last two pre-treatment outcome values.
5Olken (2015) and Coffman & Niederle (2015) evaluate the use of pre-analysis plans in social sciences.
For randomized control trials (RCT), the American Economic Association (AEA) launched a site to register
experimental designs. However, there is no site where one would be able to register a prospective synthetic
control study. Moreover, in many synthetic control applications both pre- and post-intervention information
would be available to the researcher before the possibility of registering the study. In this case, it would be
unfeasible to commit to a particular specification.
6There may be other dimensions in the implementation of the SC method that provide discretionary choices
for the researcher. For example, Klo¨bner et al. (2016) show that different SC estimators are obtained depending
on the software used or on how the dataset is sorted, and Dube & Zipperer (2015) mention the addition of
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the Current Population Survey (CPS), we calculate the probability that a researcher would
find at least one specification that would lead him to reject the null at 5%. If different SC
specifications lead to wildly different estimates, then the probability that a researcher would
be able to find a specification that rejects the null at 5% can be much higher than 5%,
implying significant room for specification searching. We consider six different specifications
commonly used in SC applications: (1) the mean of all pre-treatment outcome values, (2)
all pre-treatment outcome values, (3) the first half of the pre-treatment outcome values, (4)
the first three quarters of the pre-treatment outcome values, (5) odd pre-treatment outcome
values, and (6) even pre-treatment outcome values.7
We find that the probability of detecting a false positive in at least one specification
can be as high as 13% when there are 12 pre-treatment periods (22% if we consider a 10%
significance test). The possibilities for specification searching remain high even when the
number of pre-treatment periods is large. With 400 pre-treatment periods, we still find a
probability of around 11% that at least one specification is significant at 5% (21% if we
consider a 10% significance test). These results suggest that, even with a large number of pre-
treatment periods, different specifications can lead to significantly different synthetic control
units, generating substantial opportunities for specification searching. This is true both in
data generating processes with stationary and non-stationary common factors. We also find
similar results in placebo simulations using the CPS.
Abadie et al. (2010) and Abadie et al. (2015) emphasize that the SC method should only
be used if there is a vector of weights such that the weighted average of the pre-intervention
outcomes of the controls approximates well the pre-intervention outcomes of the treated unit.
Since it is expected that a researcher applying the SC method show the pre-intervention fit
of the chosen SC specification, this could potentially help reduce the scope for specification
searching, as a researcher would only be able to select among specifications that yield a good
covariates. We focus only on the choice of pre-treatment outcome values to include in the estimation of the
SC weights.
7In order to simplify the presentation of our results, we do not consider in our simulations the use of
time-invariant covariates, as is commonly used in specifications that rely on the pre-treatment outcome mean.
In Appendix A we show that our results remain valid if we consider specifications that use time-invariant
covariates as economic predictors in addition to functions of the pre-treatment outcomes. Note also that these
six specifications do not exhaust all specification options that have been considered in SC applications.
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pre-intervention fit. We still find, however, that the probability of rejecting the null in at least
one specification can be significantly higher than the nominal test size even when we restrict
the set of choices to specifications with a good pre-treatment fit. There are at least two possible
explanations for these results. First, in many SC applications, including those in Abadie &
Gardeazabal (2003), Abadie et al. (2010), and Abadie et al. (2015), the outcome variable is
non-stationary. In this case, most SC specifications will provide a good pre-treatment fit, as it
will provide a good approximation to the non-stationary trend, as shown in Ferman & Pinto
(2016). Our results suggest that, in this scenario, different SC specifications can still yield
substantially different estimators even if most specifications provide a good approximation to
the non-stationary trend.8 Second, as shown in Ferman & Pinto (2017), the SC permutation
test can lead to over-rejection if we consider the SC estimator conditional on a good pre-
treatment fit.9 This explains why we may still have significant over-rejection even when the
researcher has only a few (or even just one) specifications with a good pre-intervention fit to
choose from.10
The data-generating process (DGP) in our MC simulations also provides a way to measure
the extent to which different specifications assign positive weight to control units that should
not be considered in the synthetic control unit. Since, in our DGP, we divide units into groups
whose trends are parallel only when compared to units in the same group, the sum of weights
allocated to the units in the other groups is a measure of the relevance given by the synthetic
control method to units whose true potential outcome follows a different trajectory than the
treated one. The specification that uses the mean of the pre-treatment outcome values as
predictor misallocates remarkably more weight when compared to alternative specifications.
This result is not surprising given that, in our DGP, the expected value of the outcome
variable is the same for all groups.11 Still, this result reinforces the argument that using only
8This is the case, for example, when we consider placebo simulations with the CPS using log wages as
outcome variable.
9This happens because the test statistic for the treated unit is conditional on a good pre-treatment fit (that
is, the denominator is close to zero), while the test statistics for the placebo units are unconditional. The
over-rejection is decreasing in the probability that the SC estimator provides a good pre-intervention fit.
10This is the case, for example, when we consider placebo simulations with the CPS using male employment
rate as outcome variable.
11In their Appendix, Ferman & Pinto (2016) analyze the asymptotic properties of the SC estimator using
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the average of the pre-treatment outcome values might not capture the time-series dynamics
of the groups, which is the main goal of the SC method. Importantly, we find that excluding
this specification strongly attenuates the specification-searching problem, especially when the
number of pre-treatment periods is large, even though it does not solve the problem completely.
It is important to note that our results by no means imply that researchers that have im-
plemented the SC method did engage in specification searching. Given that this is a relatively
new method, there would not be enough papers to formally test for specification searching.12
However, given the mounting evidence that there is a high return for reporting “significant”
results and that scientists tend to engage in p-hacking, our findings raise important concerns
about the synthetic control method.13 Also, while we find room for specification searching
in the SC method, it does not imply that this problem is more relevant for the SC method
when compared to alternatives methods.14 The main conclusion of our paper is that, despite
providing a data-driven method to construct the counterfactual unit, the SC method does not
completely solve the specification-searching problem due to a lack of consensus on how the
SC weights should be estimated.
If there were a consensus on how the SC specification should be selected, then the risk of p-
hacking (at least in this dimension) would be limited. Our results on the specification that uses
the average of the pre-treatment outcome as economic predictor suggest that this specification-
searching problem in the SC method is magnified by specifications with undesirable properties.
More generally, our results suggest that restricting the set of options for researchers can
the average of the pre-treatment outcomes when the number of pre-treatment periods goes to infinity. They
show that, in this case, there is no guarantee that the SC weights will converge to weights that reconstruct the
factor loadings of the treated.
12Brodeur et al. (2016) analyzes 641 articles (providing more than 50,000 tests) published in the American
Economic Review, the Journal of Political Economy, and the Quarterly Journal of Economics. They identify
a residual in the distribution of tests that cannot be explained solely by journals favoring rejection of the null
hypothesis. Simonsohn et al. (2014) suggest the use of the p-curve as a way to distinguish between selective
reporting findings and true effects. One of the requirements to the inference from p-curve to be valid is that
we have a great pool of studies from which we can select studies and p-values that test similar hypothesis.
Given that the synthetic control estimator is a relatively recent method, there would not be enough published
papers that used this method even if we consider a wide range of journals. Therefore, it would be unfeasible
to replicate these methodologies for synthetic control applications.
13See Rosenthal (1979), Lovell (1983), De Long & Lang (1992), Simmons et al. (2011), Simonsohn et al.
(2014), and Brodeur et al. (2016).
14For example, Gardeazabal & Vega-Bayo (2016) compare the synthetic control method with a panel data
approach developed in Hsiao et al. (2012), and conclude that the SC estimator is more robust to changes in
the donor pool.
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strongly attenuate this problem. Another possible solution would be to require researchers
applying the SC method to report results for different specifications. However, it is important
to note that testing all the possible SC specifications separately would not provide a valid
hypothesis test since there would not be a defined decision rule (see White (2000)). One
alternative is to consider a test statistic for the permutation test that combines the test
statistics for all individual specifications, as suggested in Imbens & Rubin (2015). Finally,
another alternative would be to have a data-driven rule to determine which specification
should be used. As an example, Dube & Zipperer (2015) propose a mean squared prediction
error (MSPE) criterion based on the estimated post-treatment effects in placebo estimations
whose minimizer could be the focus of an analysis that uses the synthetic control method.
Finally, we also consider the possibilities for specification searching and the implementabil-
ity of the above recommendations in two empirical applications, based on Smith (2015) and
Abadie et al. (2010). In our empirical examples, we analyze three cases: one whose conclusion
is robust to specification searching, one where different specifications can reach either signif-
icant and non-significant results (clearly showing the potential for specification searching in
the synthetic control framework), and one where all results are significant, but at different
significance levels. Moreover, after applying our recommendations, we show that one can
reach a clear conclusion about the significance of the results in all three examples.
The remainder of this paper proceeds as follows. In Section 2, we provide a brief overview
of the SC estimation. We highlight the optimization problem used to find the weights. Then,
we provide Monte Carlo simulations in Section 3 and simulations with real data in Section 4.
We present our main recommendations in Section 5, and we discuss three empirical examples
in Section 6. We conclude in Section 7.
2 Synthetic Control Method and Specification Searching
Abadie & Gardeazabal (2003), Abadie et al. (2010) and Abadie et al. (2015) have recently
developed the Synthetic Control Method in order to address counterfactual questions involving
only one treated unit and a few control units. Intuitively, this method estimates the potential
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outcome of the treated unit if there were no treatment by constructing a weighted average
of control units that is as similar as possible to the treated unit regarding the pre-treatment
outcome variables and covariates. For this reason, this weighted average of control units is
known as the synthetic control unit and treatment effects can be flexibly estimated for each
post-treatment period. Below, we follow Abadie et al. (2010), explaining their estimator.
Suppose that we observe data for (J + 1) ∈ N units during T ∈ N time periods. Addition-
ally, assume that there is a treatment that affects only unit 1 from period T0 + 1 to period
T uninterruptedly, where T0 ∈ (1, T ) ∩ N. Let the scalar Y 0j,t be the potential outcome that
would be observed for unit j in period t if there were no treatment for j ∈ {1, ..., J + 1} and
t ∈ {1, ..., T}. Let the scalar Y 1j,t be the potential outcome that would be observed for unit j
in period t if unit j received the treatment from period T0 + 1 to T . Define:
αj,t := Y
1
j,t − Y 0j,t (1)
as the treatment effect for unit j in period t and Dj,t as a dummy variable that assumes value
1 if unit j is treated in period t and value 0 otherwise. With this notation, we have that the
observed outcome for unit j in period t is given by
Yj,t := Y
0
j,t (1−Dj,t) + Y 1j,tDj,t.
Since only the first unit receives the treatment from period T0 + 1 to T , we have that:
Dj,t :=
 1 if j = 1 and t > T00 otherwise.
We aim to identify (α1,T0+1, ..., α1,T ). Since Y
1
1,t is observable for t > T0, equation (1)
guarantees that we only need to estimate the counterfactual Y 01,t to accomplish this goal.
Let Yj := [Yj,1...Yj,T0 ]
′ be the vector of observed outcomes for unit j ∈ {1, ..., J + 1} in
the pre-treatment period and Xj a (F × 1)-vector of predictors of Yj. Those predictors can
be not only covariates that explain the outcome variable, but also linear combinations of the
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variables in Yj.
15 Let also Y0 = [Y2...YJ+1] be a (T0 × J)-matrix and X0 = [X2...XJ+1] be
a (F × J)-matrix.
Given the choice of predictors in matrix Xj, the idea of the SC method is to construct the
counterfactual for the treated unit using a weighted average of the control units:
Ŷ 01,t :=
J+1∑
j=2
ŵjYj,t (2)
The weights Ŵ = [ŵ2...ŵj+1]
′ := Ŵ(V̂) ∈ RJ are given by the solution to a nested
minimization problem:
Ŵ(V) := arg min
W∈W
(X1 −X0W)′V(X1 −X0W) (3)
where W :=
{
W = [w2...wJ+1]
′ ∈ RJ : wj ≥ 0 for each j ∈ {2, ..., J + 1} and
∑J+1
j=2 wj = 1
}
and V is a diagonal positive semidefinite matrix of dimension (F × F ) whose trace equals
one. Moreover,
V̂ := arg min
V∈V
(Y1 −Y0Ŵ(V))′(Y1 −Y0Ŵ(V)) (4)
where V is the set of diagonal positive semidefinite matrix of dimension (F × F ) whose trace
equals one.
Finally, we define the Synthetic Control Estimator of α1,t (or the estimated gap) as
α̂1,t := Y1,t − Ŷ N1,t (5)
for each t ∈ {1, ..., T}.
Intuitively, Ŵ is a weighting vector that measures the relative importance of each unit in
the synthetic control of unit 1 and V̂ measures the relative importance of each one of the F
predictors. Abadie et al. (2010) discuss alternative ways to choose the matrix V̂. We focus
15For example, if the outcome variable is a country’s per capita GDP and T0 = 12, Xj may contain the
investment rate, some measures of human capital and institutional quality, population, and the average per
capita GDP from 1 to 4, from 5 to 8 and from 9 to 12.
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our attention on the most common method of choosing V̂, which involves solving the nested
minimization problem given by equations (3) and (4).
Even though a crucial part in the implementation of the SC method is the choice of
economic predictors, there is little guidance about which variables should be included in matrix
Xj. This lack of guidance can create an opportunity for the researcher to look for a significant
estimate by including or excluding some pre-treatment outcome values from its specification.
This risk is even greater when we consider that there is no consensus about which functions
of the outcome values should be included in Xj: Abadie & Gardeazabal (2003), Abadie
et al. (2015) and Kleven et al. (2013) use the mean of all pre-treatment outcome values and
additional covariates; Smith (2015) uses Yj,T0 , Yj,T0−2, Yj,T0−4 and Yj,T0−6; Abadie et al. (2010)
picks Yj,T0 , Yj,T0−8 and Yj,T0−13; Billmeier & Nannicini (2013), Bohn et al. (2014), Gobillon &
Magnac (2016), Hinrichs (2012) use all pre-treatment outcome values; and Montalvo (2011)
uses only the last two pre-treatment outcome values.16
Abadie et al. (2015) propose an inference procedure that consists in a straightforward
placebo test. They permute which unit is assumed to be treated and estimate, for each
j ∈ {2, ..., J + 1} and t ∈ {1, ..., T}, α̂j,t as described above. Then, they compute the test
statistic
RMSPEj :=
∑T
t=T0+1
(
Yj,t − Ŷ Nj,t
)2/(T − T0)∑T0
t=1
(
Yj,t − Ŷ Nj,t
)2/T0
where the acronym RMSPE stands for ratio of the mean squared prediction errors. Moreover,
they propose to calculate a p-value
p :=
∑J+1
j=1 1 [RMSPEj ≥ RMSPE1]
J + 1
, (6)
where 1[] is the indicator function of event , and reject the null hypothesis of no effect if p
is less than some pre-specified significance level, such as the traditional value of 0.05. Abadie
et al. (2010) recognize that the randomization inference assumptions are very restrictive for
16By no means we imply that those authors have engaged in specification searching. We have only listed
them as prominent examples of different choices regarding predictor variables.
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the SC set-up. However, in the absence of random assignment, they interpret the p-value as
the probability of obtaining an estimate value for the test statistics at least as large as the
value obtained using the treated case as if the intervention was randomly assigned among the
data.17
3 Monte Carlo Simulations
In order to verify the possibility of specification searching, we elaborate a Monte Carlo
exercise in which we generate 5,000 data sets and, for each one of them, test the null hy-
pothesis of no effect whatsoever adopting several different specifications. Conditional on a
given specification, this placebo test should provide a rejection rate of α% under the null
for a α% significance test by construction. We are interested, however, in the probability of
rejecting the null hypothesis at the 5%-significance level for at least one specification. If differ-
ent specifications result in wildly different SC estimators, then the probability of finding one
specification that rejects the null at α% can be significantly higher than α%. In the extreme
case in which we have K different specifications and these specifications lead to independent
estimators, this probability would be given by 1−(1−α)K , where K is the number of different
specifications.18 In this case, such lack of guidance about which specifications should be used
could generate substantial opportunities for specification searching. In contrast, if different
SC specifications lead to similar SC weights, then this rejection rate will be close to α%
and the risk of specification searching would be very low. We consider two data generating
processes. In Section 4 we consider placebo simulations with the CPS.
In the first data generating process (DGP), we consider a linear factor model in which all
units are divided into groups that follow different stationary time trends.
Y 0j,t = δt + λ
k
t + j,t (7)
17Firpo & Possebom (2016) discuss this inference procedure in the case of random assignment, while Ferman
& Pinto (2017) analyze the statistical properties of this placebo test when treatment is not randomly assigned.
For our purposes in this paper, we consider Abadie et al. (2010) interpretation of the placebo test p-value.
18Lovell (1983) provides a similar formula, but considering the decision on which variables to include in a
regression model.
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for some k = 1, ...,K. We consider the case in which J+1 = 20 and K = 10. Therefore, units
1 and 2 follow the trend λ1t , units 3 and 4 follow the trend λ
2
t , and so on. We consider that
λkt is normally distributed following an AR(1) process with 0.5 serial correlation parameter,
δt ∼ N(0, 1) and j,t ∼ N(0, 0.1).
In our second DGP, we modify the linear factor model such that a subset of the common
factors are non-stationary. In this case, we consider DGP which includes a non-stationary
trend φrt that follows a random walk:
Y 0j,t = δt + λ
k
t + φ
r
t + jt (8)
for some k = 1, ...,K and r = 1, ..., R. We consider in our simulations K = 10 and R = 2.
Therefore, units j = 2, ..., 10 follow the same non-stationary path φ1t as the treated unit,
although only unit j = 2 also follows the same stationary path λ1t as the treated unit.
In both models, we impose that there is no treatment effect, i.e., Yj,t = Y
0
j,t = Y
1
j,t for
each time period t ∈ {1, ..., T0}. We fix the number of post-treatment periods T − T0 = 10
and we vary the number of pre-intervention periods in the DGPs, T0 ∈ {12, 32, 100, 400}. In
the Appendix, we consider variations in our stationary model (7) by setting (i) j,t ∼ N(0, 1),
(ii) K = 2, or (iii) including time-invariant covariates. We find similar results as the ones
presented in the main text.
We calculate the SC estimator using the following six specifications that differ only in the
linear combinations of pre-treatment outcome values used as predictors:19
1. Pre-treatment outcome mean: Xj = [
∑T0
t=1 Yj,t/T0]
2. All pre-treatment outcome values: Xj = [Yj,1 · · ·Yj,T0 ]′
3. The first half of the pre-treatment outcome values: Xj =
[
Yj,1 · · ·Yj,T0/2
]′
4. The first three fourths of the pre-treatment outcome values: Xj =
[
Yj,1 · · ·Yj,3T0/4
]′
19In order to compute the SC estimator, we use the Synth package in R. (See Abadie et al. (2011) for
details.) This package solves the nested minimization problem described by equations (3) and (4). We specify
the optimization method to be BFGS only and use optimization routine Low Rank Quadratic Programming
when Interior Point optimization routine does not converge.
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5. Odd pre-treatment outcome values: Xj =
[
Yj,1 Yj,3 · · ·Yj,(T0−3) Yj,(T0−1)
]′
6. Even pre-treatment outcome values: Xj =
[
Yj,2 Yj,4 · · ·Yj,(T0−2) Yj,T0
]′
In order to simplify the presentation of our results, we do not consider in our MC simula-
tions the use of time-invariant covariates, as is commonly used in specifications that rely on
the pre-treatment outcome mean. In Appendix A we show that our results remain valid if we
consider specifications that use time-invariant covariates as economic predictors in addition
to functions of the pre-treatment outcomes.
For each specification, we run a permutation test using the RMSPE test statistic proposed
in Abadie et al. (2010) and reject the null at 5%-significance level if the treated unit has the
largest RMSPE among the 20 units. By construction, this leads to a 5% rejection rate when
we look at each specification separately. We are interested, however, in the probability that
we would reject the null at the 5%-significance level in at least one specification. This is the
probability that a researcher would be able to report a significant result even when there is
no effect if she were to engage in specification searching. If all different specifications result
in the same synthetic control unit, then we would find that the probability of rejecting the
null in at least one specification would be equal to 5% as well. However, this probability may
be higher if the synthetic control weights depend on specification choices.
We present in columns 1 and 2 of Table 1 the probability of rejecting the null at 5% and
at 10% significance levels in at least one specification for the stationary model. Columns 3
and 4 present the same results for the non-stationary model.20 With T0 = 12, a researcher
considering these six different specifications would be able to report a specification with sta-
tistically significant results at the 5% level with probability 12.7% for the stationary model
and 12.4% for the non-stationary. If we consider 10% significance tests, then the probability
of rejecting the null in at least one specification would be up to 22.5% and 22.1%, respectively
for the stationary and the non-stationary models. Therefore, with few pre-treatment periods,
a researcher would have substantial opportunities to select statistically significant specifica-
tions even when the null hypothesis is true. Importantly, note that it is not unusual to have
20See table A.1 for results using different data generating processes.
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SC applications with as few as 12 pre-intervention periods.21
If the variation in the synthetic control weights across different specifications vanishes when
the number of pre-treatment periods goes to infinity, then we would expect this probability to
get closer to 5% once the number of pre-treatment periods gets large. In this case, all different
specifications would provide roughly the same synthetic control unit and, therefore, the same
treatment effect estimate. The results in Table 1 show that the probabilities of rejecting the
null are still significantly higher than the test size even when the number of pre-intervention
periods is large. In a scenario with 400 pre-intervention periods, in the non-stationary model
it would be possible to reject the null in at least one specification 11.8% (21.4%) of the time
for a 5% (10%) significance test.22 These results suggest that specification searching remains
a problem for the SC method even when the number of pre-intervention periods is remarkably
large for empirical applications.
In the previous exercise, we assumed that the researcher would be able to choose any
of the 6 specifications we considered in our MC simulations. However, Abadie et al. (2010)
and Abadie et al. (2015) emphasize that the SC control estimator should only be used in the
situations with good pre-treatment fit, i.e., in situations in which the weighted average of
the controls’ pre-treatment outcomes is a good approximation for the treated pre-treatment
outcome. It is important, therefore, to check whether the specification-searching problem we
identified in the SC method arises because we allow the researcher to choose specifications
that provide a poor pre-treatment fit. We consider a pre-treatment normalized mean squared
error index to determine whether a specification provides a good pre-treatment fit:23
21See, for example, Abadie & Gardeazabal (2003), Kleven et al. (2013), Kreif et al. (2015), Smith (2015),
Ando (2015), Liu (2015), Sills et al. (2015), Billmeier & Nannicini (2013), Bohn et al. (2014), Cavallo et al.
(2013), Hinrichs (2012), Montalvo (2011), Li (2012) and Hosny (2012).
22Note that the probability of specification searching is not monotonic in T0. This happens because, with
a very small T0, the chance that a pre-treatment MSPE is close to zero is very high. Since there is a high
correlation of pre-treatment MSPE across specifications, it is likely that one unit will have a pre-treatment
MSPE close to zero for many specifications. This implies that this unit will have a large test statistic for all
these specifications, so the placebo test will reject the null for these specifications most of the time. As T0
increases, the probability of having a pre-treatment MSPE close to zero will be small.
23This measure is very similar to the “pretreatment fit index” proposed by Adhikari & Alm (2016). These
authors propose a measure that is the ratio between the squared root of the mean squared predicted error
(the numerator of 1 − R˜2) and
√∑T0
t=1 Y
2
1t
T0
. The advantage of our measure relative to the one proposed by
Adhikari & Alm (2016) is that our measure is invariant to linearly additive changes. Dube & Zipperer (2015)
14
R˜2 = 1−
∑T0
t=1
(
Y1,t − Ŷ N1,t
)2
∑T0
t=1
(
Y1,t − Y 1
)2 (9)
where Y 1 =
∑T0
t=1 Y1,t
T0
. If this measure is one, then we have a perfect fit.24
In order to capture a good fit, we consider two thresholds for R˜2, R˜2 > 0.80 and R˜2 > 0.95.
Considering these two thresholds, panel A of Table 2 shows the probability of finding a
good pre-treatment fit for at least one of the six specifications.25 The probability of finding
specifications with a good pre-treatment fit depends crucially on how we define whether a
specification provided a good fit and on whether we consider a stationary or a non-stationary
model. We present in columns 1 and 2 the results for the stationary model. With a moderate
T0, the probability of finding at least one specification with good fit is close to one when
we consider the weaker definition of good fit, and close to zero when we consider the more
stringent definition. Even when we consider the weaker definition of good fit, it is interesting
to note that the average number of specifications with good fit is close to 5 (panel B of
Table 2). This happens because the probability of having a good fit for the specification
that uses the pre-treatment mean as economic predictor is relatively low (panel C of Table
2). We present in columns 3 and 4 the results for the non-stationary model. In this case,
the probability of having at least one specification with a good fit is close to one even when
we consider the more stringent definition of good fit. Also, there is a high probability that
all specifications (including the specification that uses the pre-treatment mean as economic
predictor) provide a good fit, especially when T0 is large. This happens because, with large T0,
the non-stationary factors dominate the variance of Y1,t. Since the SC estimator is extremely
efficient in controlling for the non-stationary factors (see Ferman & Pinto (2016)), it will
usually provide a good pre-treatment fit.
Given these definitions of good fit, we present in Table 3 the probabilities of rejecting the
also propose a pre-treatment fit criterion that is equal to the numerator of our measure, the root of the mean
squared error predictor between the synthetic and the actual outcomes in the pre-treatment period. However,
differently from our suggestion, their measure is not scale invariant.
24Note that, differently from the standard R2 measure, R˜2 can be negative.
25See table A.2 for results using different data generating processes.
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null in at least one specification when we restrict the researcher to consider only specifications
that provide a good pre-treatment fit.26 Note that the possibilities for specification searching
in the non-stationary model (columns 3 and 4) are virtually the same as when we do not
restrict for specifications with a good pre-treatment fit, especially when T0 is large (columns
3 and 4 of Table 1). This is not surprising, given that all specifications will usually provide
a good pre-treatment fit in this model. For the stationary model (columns 1 and 2 of Table
3), the specification-search problem is attenuated when we restrict to specifications with a
good fit if we use the more lenient definition of good fit (panel A). In practice, in this case
the restriction of considering only specifications with a good fit prevents the researcher from
choosing the specification that uses the pre-treatment mean as economic predictor, whose
weights, as we show below, are very different from the ones chosen by the other specifications.
If we consider the more stringent definition of good fit, however, then the probability of
rejecting the null in at least one specifications is substantially higher (panel B). This happens
because, if we consider that the SC method should only be used when the pre-treatment fit
is good (as suggested in Abadie et al. (2010) and Abadie et al. (2015)), then there is a low
probability of finding a good fit for at least one specification and we would only consider
specifications such that the denominator of the test statistic for the treated unit is close to
zero. Since the test statistic for the placebo units are not conditional on a good pre-treatment,
this leads to over-rejection, as shown in Ferman & Pinto (2017).
Overall, these results suggest that restricting the researcher to consider only specifica-
tions with a good fit does not necessarily attenuate the specification-searching problem. On
the one hand, if conditioning on a good fit does not actually restrict the set of options a
researcher has (as happens with our non-stationary model), then we have the same results
as in the unconditional case. On the other hand, if conditioning severely restricts the set of
options, then we have over-rejection because the test statistic for the treated unit is condi-
tional on a denominator that is close to zero, while the test statistics for the placebo units
are unconditional.
The results so far indicate that different specifications can provide substantially different
26See table A.3 for results using different data generating processes.
16
SC estimators. An interesting feature of our MC simulations is that the SC estimator should
assigned positive weights only for unit 2 (which has the same factor loadings of unit 1), so
we can actually calculate the proportion of weights that is misallocated for each specification.
We present in columns 1 to 6 of Table 4 the proportion of misallocated weights for each spec-
ification in different scenarios.27 Interestingly, specification 1 (which uses the pre-treatment
mean as economic predictor) misallocates substantially more weights relative to the other
specifications. For the stationary model (panel A), with T0 = 12, specification 1 misallocates
more than 80% of the weights, while the misallocation for other specifications ranges from
23% to 29%. The misallocation of weights decreases with T0 for all specifications, except
for specification 1. Results are qualitatively the same for the non-stationary model (panel
B). These results suggest that using the pre-treatment outcome mean might not capture the
time-series dynamics of the units, which is the main goal of the SC method.28
We also calculate a measure of variability of weights. For each unit in the donor pool we
look for the specifications that allocate the most and the least weight for this unit. Then
we take the maximum value of this difference across units in the donor pool. We present
this measure in column 7 of Table 4.29 Interestingly, this measure does not decrease in T0,
suggesting that increasing T0 does not imply that different SC specifications will lead to
similar SC estimators. If we consider this measure excluding specification 1, however, then
it decreases in T0 (column 8 of Table 4). These results indicate that, as T0 increases, the
SC estimators using specifications 2 to 6 become more similar. However, the SC estimator
using specification 1 can be considerably different from the SC estimators using the other
specifications even when T0 is large. This result is intuitive, given that specifications 2 to 6
exploit the time-series dynamics of the data, while specification 1 does not.30
27See table A.4 for results using different data generating processes.
28In specifications that use other covariates in addition to the pre-treatment mean, the matrix V would be
chosen to minimize the pre-treatment MSPE in the second step of the optimization process, so this estimator
would somewhat take the time-series dynamics of the outcome into account. However, this would be very
limited because the first minimization problem can severely restrict the set of possible weights W∗(V ) that
may be chosen in the second step, as suggested in Ferman & Pinto (2016).
29See table A.4 for results using different data generating processes.
30In Appendix A we show that specification 1 can fail to properly exploit the time-series dynamics of the data
even if we also include time-invariant covariates as economic predictors. In this case, it will still remain different
from the specifications that use pre-treatment outcome lags as economic predictors, even when the number
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Given that the specification that uses the pre-treatment mean as the economic predictor
stands out by misallocating significantly more weights, in Table 5 we consider the specification-
searching possibilities excluding specification 1.31 Excluding specification 1 significantly at-
tenuates the specification-searching problem, especially when the number of pre-treatment
periods is large, although it does not completely solve the problem.32 This attenuation in the
specification-searching problem is not simply because we are considering five specifications
instead of six. If we exclude, for example, specification 2 instead of specification 1, then there
is virtually no change in the specification-search problem relative to the case that we consider
six specifications (Appendix Table A.6).
4 Simulations with Real Data
The results presented in Section 3 suggest that different specifications of the SC method
can generate significant specification-searching opportunities. We now check whether the
results we find in our MC simulations are also relevant when we consider real datasets by
conducting simulations of placebo interventions with the Current Population Survey (CPS).
We use the CPS Merged Outgoing Rotation Groups for the years 1979 to 2014. Following
Bertrand et al. (2004), we extract information on employment status and earnings for women
between ages 25 and 50. We also consider in a separate set of simulations information on
men in the same age range. Before we proceed to the placebo simulations, we briefly discuss
the raw data for these outcome variables. There are important distinctions in the time series
characteristics when we consider information for men versus women and when we consider
log wages versus employment. Figures 1a and 1b present the time series of log wages for
all US states, respectively for men and women. As expected, the time series of log wages is
of pre-treatment periods is large. Therefore, our result that the possibilities of specification searching may
not diminish with the number of pre-treatment periods when we consider the specification that uses the pre-
treatment outcome mean as economic predictor remains valid even if we consider the addition of time-invariant
variables as economic predictors.
31See table A.5 for results using different data generating processes.
32The only exception is when we consider the stationary model conditional on a good fit with R˜2 > 0.95.
This happens because, in this case, there is a low probability that we find at least one specification with a
good fit.
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non-stationary and increasing for both men and women. These graphs suggest that there is a
strong non-stationary factor that affects all states in the same way. Figures 1c and 1d present
the time series of employment for all US states, respectively for men and women. In this case,
the time series for men should be closer to our stationary model from Section 3, while the
time series for women has an increasing trend in the 80s and 90s.
We first consider simulations with 12 pre-intervention periods, 4 post-intervention periods,
and 20 states. In each simulation, we randomly select one treated and 19 control states out
of the 51 states (including Washington, D.C.) and then we randomly select the first period
between 1979 and 1999. Then we consider simulations with 32 pre-intervention periods, 4
post-intervention periods, and 20 states. In this case, we randomly select 20 states and
use the entire 36 years of data. In each scenario, we run 5,000 simulations using either
employment or log wages as the dependent variable and test the null hypothesis using the
same six specifications of Section 3.
We start presenting the probability of finding specifications with a good fit in Table 6.
When the outcome variable is log wages, the probability of having at least one specification
with a good fit is close to one, especially when we consider T0 = 32 (columns 1 to 4, panel A).
Also, when we consider T0 = 32, the number of specifications with a good fit is close to 6, which
suggests that there is a high probability that all specifications will provide a good fit (columns
1 to 4, panel B). These results are consistent with our MC simulations considering that the
log wages series appear to have important non-stationary common factors. The probability
of finding specifications with a good fit is lower when we consider employment instead of log
wages as outcome variable, and even lower when we consider men relative to women. This is
consistent with the employment time series for men being closer to a stationary process.
We present in Table 7 the probabilities of rejecting the null in at least one specification.33
In panel A, we present the unconditional specification-searching probabilities. The results
are very similar to our findings in the MC simulations. With T0 = 12, depending on the
sample and outcome variable, there is 10-12% probability of finding a specification with sta-
33Standard errors for these simulation results are clustered at the treated-state level, in order to take into
account that the simulations are not independent.
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tistically significant results at 5% and a 19-21% probability of finding a specification with
statistically significant results at 10%. With T0 = 32 these probabilities are slightly lower,
but still significantly higher than the test nominal size. In panels B and C we present results
restricting the choices to specifications with a good pre-treatment fit. As in our MC sim-
ulations, conditioning on a good fit does not attenuate the specification-searching problem.
When we consider log wages as outcome variable, conditioning does not affect much these
probabilities, as most specifications provide a good fit, especially when T0 = 32. When we
consider employment as outcome variable, conditioning leads to over-rejection because there
is a high probability that no specification provides a good fit and the surviving specifications
present a pre-treatment fit (the denominator of the test statistic) that is much lower than
the pre-treatment fit of the control units, that are not restricted to have a good fit. These
results suggest that specification-searching possibilities in SC applications can be relevant in
real applications of the SC method.
We also consider in Table 8 the specification-searching probabilities excluding the specifica-
tion that uses the pre-treatment mean as economic predictor. Similar to our MC simulations,
excluding this specification attenuates the specification-searching problem, although it does
not completely solve the problem. With T0 = 32, the probability of rejecting the null at 5%
in at least one specification ranges from 7% to 7.9% depending on the sample and outcome
variable, and in no case we can reject that this probability is different from the nominal
test size. Again, this attenuation is not a simple mechanical effect due to the fact that we
are considering fewer specifications. In Appendix Table A.7, we show that there is virtually
no change in the probabilities of rejecting the null in at least one specification when we ex-
clude specification 2 (instead of specification 1) relative to the case where we consider all six
specifications.
5 Recommendations
The specification-searching problem we identify arises from a lack of consensus about which
specifications should be used in SC applications. Our first recommendation is that researchers
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should only consider specifications that capture the dynamic of the outcome of the treated
unit in the pre-treatment period, because our results suggest that the specification-searching
problem is magnified by specifications with undesirable properties, such as the specification
that uses only the mean pre-treatment outcome as economic predictor. If we discard this
specification, then the specification-searching problem is attenuated, especially if we have a
large number of pre-treatment periods, even though it does not solve the problem completely.
We also recommend that researchers applying the SC should report results for different
specifications. However, even if a researcher present results for all possible SC specifications
with an hypothesis test for each specification, this would not provide a valid hypothesis test.
If the decision rule is to reject the null if the test rejects in all specifications, then we could end
up with a very conservative test (Romano & Wolf (2005)).34 If the decision rule is to reject
the null if the test rejects in at least one specification, then we would be back in the situation
where we over-reject the null. One possible solution is to base the inference procedure on
a new test statistic that is a function that combines all the test statistics for the individual
specifications, as suggested by Imbens & Rubin (2015). Although this function can be non-
linear, if it is simply a weighted average of the test statistics for individual specifications, then
Christensen & Miguel (2016) and Cohen-Cole et al. (2009) suggest using the same weights
to compute a weighted average of the point-estimator of each specification and using this
weighted average as an estimate that incorporates model uncertainty.
Another possibility is to consider a criterion for choosing among all possible specifications.
If one restricts attention to only one specification that is chosen based on an objective cri-
terium, without the need of subjective decisions by the researcher, then the possibility for
specification searching would be limited, at least in this dimension. One such possibility is to
follow Dube & Zipperer (2015) and choose the specification that minimizes the mean squared
prediction error (MSPE) for the post-intervention periods for the placebo estimates.
34When we adopt this decision rule in our MC simulations, then probability of rejecting the null at 5% for
all specifications is lower than 1% in all scenarios. If we discard specification 1, then this rejection rate ranges
from 1% when T0 = 12 to 2.8% when T0 = 400.
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6 Empirical Applications
We analyze the possibilities for specification searching and the implementability of our
recommendations in two empirical examples.
6.1 The resource curse exorcised: Evidence from a panel of countries
(Smith (2015))
Smith (2015) evaluates the impact of major natural resource discoveries since 1950 on
GDP per capita using different methods, including the synthetic control method.35 Ma-
jor oil and gas discoveries happened in Equatorial Guine and Equator in 1992 and 1972
respectively, implying that pre and post-treatment periods are 1950-1991 and 1992-2008
for the first country and 1950-1971 and 1972-2008 for the second one. While the donor
pool for Equatorial Guine consists of Sub-Saharan African Countries (Benin, Burkina Faso,
Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Cote d’Ivoire, Gambia,
Ghana, Guinea, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauri-
tius, Mozambique, Namibia, Niger, Rwanda, Senegal, Somalia, Sudan, Swaziland, Tanzania,
Togo, Uganda, Zambia, Zimbabwe), the donor pool for Ecuador consists of Latin American
and Caribbean countries (Costa Rica, Cuba, Dominican Republic, El Salvador, Guatemala,
Honduras, Jamaica, Nicaragua, Panama, Paraguay, Puerto Rico, Uruguay).
We estimate the impact of major oil and gas discoveries on GDP per capita using the
synthetic control method with twelve different specifications. Specifically, we test six different
specifications that differ in which functions of the pre-treatment periods are included and, for
each one of them, we either include the covariates ethnic fragmentation and population size
one year before the discovery or not. Our the six basic specifications are:36
35Following the best practices in terms of transparency and replicability, he made his dataset and replication
files available online (http://www.brockdsmith.com/research.html).
36Although the number of pre-treatment years is larger than seven, we followed Smith (2015) and considered
for this exercise different specifications using only seven years of pre-treatment data in the first minimization
problem (equation (3)) while accounting for the entire pre-treatment period in the second minimization problem
(equation (4)). Had we considered only seven years of pre-treatment data in the second step, we would reach
similar conclusions to the ones in the main text. Had we considered the same specifications using the full pre-
treatment data in the first step, then we would fail to reject the null for all specifications. This is consistent
with our result that the variation between specifications that use pre-treatment outcome lags as economic
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1. Original Specification (Even pre-treatment outcome values): Xj =
[
Yj,(T0−6) Yj,(T0−4) Yj,(T0−2) Yj,T0
]′
2. Pre-treatment outcome mean: Xj = [
∑T0
t=T0−6 Yj,t/7]
3. All pre-treatment outcome values: Xj =
[
Yj,(T0−6) · · ·Yj,T0
]′
4. The first half of the pre-treatment outcome values: Xj =
[
Yj,(T0−6) · · ·Yj,(T0−4)
]′
5. The first three fourths of the pre-treatment outcome values: Xj =
[
Yj,(T0−6) · · ·Yj,(T0−2)
]′
6. Odd pre-treatment outcome values: Xj =
[
Yj,(T0−5) Yj,(T0−3) Yj,(T0−1)
]′
where T0 = 1991 for Equatorial Guine and T0 = 1971 for Ecuador.
Table 9 shows the p-value and our goodness of fit measure for each specification and
each country. On the one hand, the results for Equatorial Guinea are robust to specification
searching, since all specifications provide treatment effect estimates that are significant at
the 5%-level. On the other hand, the results for Ecuador show that the researcher could
try different specifications and pick one whose result is significant. In particular, all twelve
specifications have a good fit (R˜2 > 0.80), but only two of them are significant (specifications
(2b) and (6b)), implying that the researcher could, potentially, report a false-positive result.37
We now test our recommendations in these particular applications. First of all, by pre-
senting results for more than one specification as we do in Table 9, a sensible conclusion would
be that major oil and gas discoveries had a significant effect on Equatorial Guinea’s GDP per
capita even though there is no evidence of such effect on Ecuador’s GDP per capital. Figure
2 shows that this conclusion is reasonable since, in the case of Equatorial Guinea, we find
that all specifications with a good fit have estimates of similar magnitude while, in the case
of Ecuador, our results vary widely across specifications. The next step is to test the null hy-
pothesis using a test statistics that combine the test statistics of all specifications. Restricting
ourselves to specifications with good fit (R˜2 > 0.80), we find that the p-value of a test that
uses the mean of the RMSPE statistic across specifications, as suggested by Imbens & Rubin
predictor diminishes when the number of pre-treatment periods increases. Results are available upon request.
37 We stress that the specification considered by Smith (2015) is not one of these two that would have led
him to conclude that there is a significant effect.
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(2015), is equal to 0.031 and 0.308 for Equatorial Guinea and Ecuador, corroborating our
conclusion that the treatment effect is positive in the first case and zero in the second one.
Now, following the suggestion of Christensen & Miguel (2016) and Cohen-Cole et al. (2009),
figure 3 shows the average treatment effect across specifications with good fit as a black line
and the associated placebo effects as gray lines. Clearly, the effects for Equatorial Guinea and
Ecuador are, respectively, large and small when compared to their empirical distributions.
Finally, we apply the MSPE criterion suggested by Dube & Zipperer (2015) to select only
one specification. For Equatorial Guinea, we find that specification 5b (first three-fourths of
pre-treatment outcome values without covariates) minimizes the MSPE criterion, and the the
p-value for this specification is 0.031 . For Ecuador, we find that specification 5b (first three-
fourths pre-treatment outcome values without covariates) minimizes the MSPE criterion, and
the p-value for this specification is 0.308. Figure 4 shows the treatment effect and the placebo
effects for specifications 5b for Equatorial Guinea and Ecuador, respectively.
The results based on the recommendations by Imbens & Rubin (2015), Christensen &
Miguel (2016) and Cohen-Cole et al. (2009) point all to the same direction. Therefore, a
reasonable conclusion would be that the treatment effect is significant in the case of Equatorial
Guinea and statistically zero in the case of Ecuador. Importantly, without following these
recommendations, the results for Ecuador point out that it would be possible to find particular
specifications with a good pre-treatment fit that would lead the researcher to conclude that
the effect for Ecuador is statistically significant.
6.2 Synthetic Control Methods for Comparative Case Studies: Estimat-
ing the Effect of California’s Tobacco Control Program (Abadie et al.
(2010))
Abadie et al. (2010) evalute the effect of Proposition 99, a large-scale tobacco control
program that California implemented in 1988, on annual per-capita cigarette sales.38 The pre
and post-treatment periods are 1970-1988 and 1989-2000. The donor pool includes thirty-
38Following the best practices in terms of transparency and replicability, they made their dataset and repli-
cation files available through the command synth in the software Stata.
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eight American states (Alabama, Arkansas, Colorado, Connecticut, Delaware, Georgia, Idaho,
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Minnesota, Mississippi, Missouri,
Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Carolina, North Dakota,
Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee,
Texas, Utah, Vermont, Virginia, West Virginia, Wisconsin, Wyoming).
We estimate the impact of Proposition 99 on California’s annual per-capita cigarette sales
using the synthetic control method with fourteen different specifications. Specifically, we test
seven different specifications that differ in which functions of the pre-treatment periods are
included and, for each one of them, we either include the covariates average retail price of
cigarettes, per capita state personal income (logged), percentage of the population age 15–24,
and per capita beer consumption or not. The seven basic specification are (1) original speci-
fication by Abadie et al. (2010) (outcome values for 1975, 1980 and 1988), (2) pre-treatment
outcome mean, (3) all pre-treatment outcome values, (4) the first half of the pre-treatment
outcome values, (5) the first three fourths of the pre-treatment outcome values, (6) odd pre-
treatment outcome values, (7) even pre-treatment outcome values.
Table 10 shows the p-value and our goodness of fit measure for each of the 14 specifications
we considered. Note that quality of the fit varies widely across specifications: eight of them
fit the data very closely (R˜2 ≥ 0.975), five of them have an intermediate value for our measure
of goodness of fit (0.80 < R˜2 < 0.975) and one of them fit the data very poorly (R˜2 ≤ 0.80).
Most importantly, all specifications with good fit have significant estimates whose magnitude is
similar according to figure 5, although p-values vary from 0.026 (the p-value in the specification
considered in Abadie et al. (2010)) to 0.077 depending on the specification.
Now, we test the null hypothesis using a test statistic that combine the test statistics
of all specifications. Restricting ourselves to specifications with a fit as good as the original
specification (R˜2 > 0.975), we find that the p-value of a test that uses the mean of the RMSPE
statistic across specifications, as suggested by Imbens & Rubin (2015), is equal to 0.077, which
is larger than the p-value of the original specification (0.026). Hence, the treatment effect
is still significant even though the test statistic for California does not stands out as the
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largest one among all placebo runs as it does when we consider the original specification.
Additionally, figure 3 shows the average treatment effect across specifications with good fit
as a black line and the associated placebo effects as gray lines following the suggestion of
Christensen & Miguel (2016) and Cohen-Cole et al. (2009). Note that the treatment effects
for California seem to be larger (or, at least, more stable) than the placebo effects.
Finally, we apply the MSPE criterion suggested by Dube & Zipperer (2015) to select only
one specification. We find that specification 6a (odd pre-treatment outcome values) minimizes
the MSPE criterion. The p-value for this specification is 0.026. This result is consistent with
the one reached by the method suggested by Imbens & Rubin (2015), although we would
reject the null at a lower significance level.
Overall, our results suggest that the effect of the California’s tobacco control program
is significantly different from zero, although the test statistic for California is not always
the largest one among all placebo runs when we consider different specifications, even if we
consider only specifications that provide a good pre-treatment fit.
7 Conclusion
We show that a lack of specific guidance on how to choose among different SC specifications
creates the potential for specification searching with synthetic controls. We also show that
restricting the set of options a researcher has when applying the SC method can substantially
attenuate this specification-searching problem. We move in this direction by showing that
the specification that uses the average of the pre-treatment outcome may fail to exploit the
dynamics of the time series, which is the main goal of the SC method. Discarding this
specification significantly reduces the room for specification searching when the number of pre-
treatment periods is large, even though it does not completely solve the problem. However,
further research is necessary to determine in which circumstances one should use all pre-
treatment lags as economic predictors or only a subset of the pre-treatment outcome lags
(and, in this case, which subset should be used). Consequently, additional restrictions on the
set of specifications applied researchers can use when employing the SC method in a given
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application can further reduce the scope for specification searching with synthetic controls.
Furthermore, we also recommend that researchers report results using different specifications,
and we suggest alternatives to take into account the fact that the treatment effect can be
estimated using different specifications. Finally, we show that these recommendations can
easily be implemented in practice, providing clear conclusions about the significance of an
estimate.
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Figure 1: Outcome trajectories in the CPS data
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Notes: We present the time series of log wages and employment rates for all US states separately by men
and women.
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Figure 2: Treatment Effects for All Specifications - Database from Smith (2015)
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Notes: Gray lines have R˜2 ≤ 0.80, dashed lines have 0.80 < R˜2 ≤ 0.95 and solid black lines have R˜2 > 0.95,
where R˜2 is defined by equation (9). The vertical lines denote the beginning of the post-treatment period.
Figure 3: Placebo Effects Using the Average Across Specifications - Database from
Smith (2015)
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Notes: We only consider specifications that satisfy R˜2 > 0.80 to compute the average treatment effect across
specification, where R˜2 is defined by equation (9). Gray lines are the placebo effects of the control countries
and the black line is the treatment effect of the treated country. The vertical lines denote the beginning of the
post-treatment period.
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Figure 4: Placebo Effects Using the MSPE Criterion - Database from Smith (2015)
(a) Equatorial Guinea - Specification (6b)
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(b) Ecuador - Specification (2b)
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Notes: We only consider specifications that satisfy R˜2 > 0.80 when minimizing the MSPE criterion (Dube &
Zipperer (2015)) across specifications, where R˜2 is defined by equation (9). Gray lines are the placebo effects
of the control countries and the black line is the treatment effect of the treated country. The vertical lines
denote the beginning of the post-treatment period.
Figure 5: Treatment Effects for All Specifications - Database from Abadie et al.
(2010)
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Notes: The solid black line is the original specification by Abadie et al. (2010), whose measure of goodness of
fit is R˜2 = 0.0975, where R˜2 is defined by equation (9). Gray lines have R˜2 ≤ 0.975 and dashed lines have
R˜2 > 0.975. The vertical line denotes the beginning of the post-treatment period.
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Figure 6: Placebo Effects Using the Average Across Specifications - Database from
Abadie et al. (2010)
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Notes: We only consider specifications that satisfy R˜2 > 0.0975 to compute the average treatment effect across
specification, where R˜2 is defined by equation (9) Gray lines are the placebo effects of the control state and the
black line is the treatment effect of California. The vertical line denotes the beginning of the post-treatment
period.
Figure 7: Placebo Effects Using the MSPE Criterion (Specification 5a) - Database
from Abadie et al. (2010)
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Notes: We only consider specifications that satisfy R˜2 > 0.975 when minimizing the MSPE criterion (Dube &
Zipperer (2015)) across specifications, where R˜2 is defined by equation (9). Gray lines are the placebo effects
of the control states and the black line is the treatment effect of California. The vertical line denotes the
beginning of the post-treatment period.
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Table 1: Specification searching
Stationary Model Non-stationary Model
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
T0 = 12 0.127 0.225 0.124 0.221
(0.005) (0.006) (0.005) (0.006)
T0 = 32 0.128 0.234 0.137 0.240
(0.005) (0.006) (0.005) (0.006)
T0 = 100 0.122 0.222 0.130 0.236
(0.005) (0.006) (0.005) (0.006)
T0 = 400 0.114 0.212 0.118 0.214
(0.005) (0.006) (0.005) (0.006)
Note: Rejection rates are estimated based on 5,000 observations and on
six specifications — (1) the mean of all pre-treatment outcome values, (2)
all pre-treatment outcome values, (3) the first half of the pre-treatment
outcome values, (4) the first three quarters of the pre-treatment out-
come values, (5) odd pre-treatment outcome values, and (6) even pre-
treatment outcome values. z% test indicates that the nominal size of
the analyzed test is z% and T0 is the number of pre-treatment periods.
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Table 2: Probability of good pre-treatment fit
Stationary model Non-stationary model
R˜2 > 0.80 R˜2 > 0.95 R˜2 > 0.80 R˜2 > 0.95
(1) (2) (3) (4)
Panel A: At least one specification with good fit
T0 = 12 0.942 0.262 0.988 0.609
(0.002) (0.004) (0.001) (0.004)
T0 = 32 0.994 0.091 1.000 0.818
(0.002) (0.004) (0.001) (0.004)
T0 = 100 1.000 0.003 1.000 0.997
(0.002) (0.004) (0.001) (0.004)
T0 = 400 1.000 0.000 1.000 1.000
(0.002) (0.004) (0.001) (0.004)
Panel B: # of specifications with good fit
T0 = 12 4.522 0.923 5.128 2.604
(0.012) (0.015) (0.008) (0.022)
T0 = 32 5.068 0.339 5.389 4.002
(0.012) (0.015) (0.008) (0.022)
T0 = 100 5.169 0.007 5.753 5.246
(0.012) (0.015) (0.008) (0.022)
T0 = 400 5.166 0.000 5.991 5.681
(0.012) (0.015) (0.008) (0.022)
Panel C: Specification 1 has a good fit
T0 = 12 0.162 0.015 0.300 0.073
(0.005) (0.001) (0.006) (0.006)
T0 = 32 0.164 0.005 0.394 0.131
(0.005) (0.001) (0.006) (0.005)
T0 = 100 0.169 0.000 0.753 0.268
(0.005) (0.001) (0.006) (0.005)
T0 = 400 0.166 0.000 0.991 0.681
(0.005) (0.001) (0.006) (0.006)
Note: Descriptive statistics are estimated based on 5,000 observations and
on six specifications — (1) the mean of all pre-treatment outcome values,
(2) all pre-treatment outcome values, (3) the first half of the pre-treatment
outcome values, (4) the first three quarters of the pre-treatment outcome
values, (5) odd pre-treatment outcome values, and (6) even pre-treatment
outcome values. T0 is the number of pre-treatment periods. Our measure
of goodness of fit is defined by equation (9). We consider two definitions of
good fit; R˜2 > 0.80 and R˜2 > 0.95.
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Table 3: Specification searching conditional on a good pre-treatment fit
Stationary Model Non-stationary Model
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
Panel A: R˜2 > 0.80
T0 = 12 0.106 0.188 0.111 0.194
(0.004) (0.005) (0.005) (0.006)
T0 = 32 0.100 0.182 0.119 0.205
(0.004) (0.005) (0.005) (0.006)
T0 = 100 0.090 0.157 0.124 0.221
(0.004) (0.005) (0.005) (0.006)
T0 = 400 0.079 0.143 0.118 0.214
(0.004) (0.005) (0.005) (0.006)
Panel B: R˜2 > 0.95
T0 = 12 0.197 0.321 0.125 0.215
(0.011) (0.013) (0.006) (0.007)
T0 = 32 0.192 0.328 0.113 0.191
(0.019) (0.022) (0.005) (0.006)
T0 = 100 0.154 0.308 0.103 0.179
(0.110) (0.130) (0.004) (0.006)
T0 = 400 - - 0.107 0.191
- - (0.004) (0.006)
Note: Rejection rates are estimated based on 5,000 observations and on
six specifications — (1) the mean of all pre-treatment outcome values, (2)
all pre-treatment outcome values, (3) the first half of the pre-treatment
outcome values, (4) the first three quarters of the pre-treatment out-
come values, (5) odd pre-treatment outcome values, and (6) even pre-
treatment outcome values. z% test indicates that the nominal size of
the analyzed test is z% and T0 is the number of pre-treatment periods.
Our measure of goodness of fit is defined by equation (9). We consider
two definitions of good fit; R˜2 > 0.80 and R˜2 > 0.95.
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Table 4: Variability and Misallocation of weights
Misallocation of weights in specification: Variability of weights
1 2 3 4 5 6 All Exclude 1
(1) (2) (3) (4) (5) (6) (7) (8)
Panel A: Stationary Model
T0 = 12 0.811 0.226 0.260 0.290 0.243 0.247 0.736 0.317
(0.005) (0.002) (0.003) (0.003) (0.003) (0.003) (0.003) (0.003)
T0 = 32 0.810 0.147 0.143 0.180 0.141 0.142 0.763 0.181
(0.005) (0.001) (0.001) (0.002) (0.001) (0.001) (0.004) (0.001)
T0 = 100 0.812 0.110 0.099 0.124 0.099 0.099 0.774 0.115
(0.005) (0.001) (0.001) (0.001) (0.001) (0.001) (0.004) (0.001)
T0 = 400 0.813 0.091 0.086 0.096 0.086 0.085 0.769 0.069
(0.005) (0.000) (0.000) (0.001) (0.000) (0.000) (0.004) (0.000)
Panel B: Non-stationary Model
T0 = 12 0.807 0.192 0.219 0.249 0.209 0.212 0.753 0.287
(0.005) (0.002) (0.003) (0.003) (0.003) (0.003) (0.004) (0.003)
T0 = 32 0.812 0.117 0.122 0.151 0.120 0.119 0.784 0.165
(0.005) (0.001) (0.001) (0.002) (0.001) (0.001) (0.004) (0.001)
T0 = 100 0.814 0.086 0.081 0.099 0.081 0.082 0.794 0.107
(0.005) (0.001) (0.001) (0.001) (0.001) (0.001) (0.004) (0.001)
T0 = 400 0.818 0.073 0.070 0.077 0.070 0.071 0.792 0.070
(0.005) (0.000) (0.000) (0.001) (0.000) (0.000) (0.005) (0.000)
Note: The average of misallocated weights is based on 5,000 observations. The reasoning behind this variable is
the following: since, in our DGP, we divide units into groups whose trends are parallel only when compared to
units in the same group, the sum of the weights allocated to the units in the other groups is a measure of the
relevance given by the synthetic control method to units whose true potential outcome follows a different trajectory
than the one followed by the unit chosen to be the treated one. The average of variability of weights is based
on 5,000 observations and captures the average maximum difference of allocated weights across specifications.
Specification s is one of the specifications used to compute the synthetic control unit: (1) the mean of all pre-
treatment outcome values, (2) all pre-treatment outcome values, (3) the first half of the pre-treatment outcome
values, (4) the first three quarters of the pre-treatment outcome values, (5) odd pre-treatment outcome values,
and (6) even pre-treatment outcome values. T0 is the number of pre-treatment periods.
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Table 5: Specification searching - Excluding specification 1
Stationary Model Non-stationary Model
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
Panel A: Unconditional
T0 = 12 0.105 0.189 0.106 0.187
(0.004) (0.005) (0.004) (0.005)
T0 = 32 0.099 0.180 0.110 0.186
(0.004) (0.005) (0.004) (0.005)
T0 = 100 0.087 0.152 0.098 0.167
(0.004) (0.005) (0.004) (0.005)
T0 = 400 0.077 0.140 0.080 0.141
(0.004) (0.005) (0.004) (0.005)
Panel B: Conditional on R˜2 > 0.80
T0 = 12 0.101 0.182 0.104 0.184
(0.004) (0.005) (0.004) (0.005)
T0 = 32 0.098 0.178 0.110 0.186
(0.004) (0.005) (0.004) (0.005)
T0 = 100 0.087 0.152 0.098 0.167
(0.004) (0.005) (0.004) (0.005)
T0 = 400 0.077 0.140 0.080 0.141
(0.004) (0.005) (0.004) (0.005)
Panel C: Conditional on R˜2 > 0.95
T0 = 12 0.192 0.316 0.124 0.214
(0.011) (0.013) (0.005) (0.007)
T0 = 32 0.187 0.326 0.111 0.188
(0.018) (0.022) (0.005) (0.006)
T0 = 100 0.154 0.308 0.098 0.168
(0.109) (0.129) (0.004) (0.005)
T0 = 400 - - 0.080 0.141
- - (0.004) (0.005)
Note: Rejection rates are estimated based on 5,000 observations and on
five specifications — (1) all pre-treatment outcome values, (2) the first
half of the pre-treatment outcome values, (3) the first three quarters
of the pre-treatment outcome values, (4) odd pre-treatment outcome
values, and (5) even pre-treatment outcome values. z% test indicates
that the nominal size of the analyzed test is z% and T0 is the number
of pre-treatment periods. Our measure of goodness of fit is defined by
equation (9). We consider two definitions of good fit; R˜2 > 0.80 and
R˜2 > 0.95.
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Table 6: Probability of good pre-treatment fit - CPS
Log wages Employment
Women Men Women Men
R˜2 > 0.80 R˜2 > 0.95 R˜2 > 0.80 R˜2 > 0.95 R˜2 > 0.80 R˜2 > 0.95 R˜2 > 0.80 R˜2 > 0.95
(1) (2) (3) (4) (5) (6) (7) (8)
Panel A: At least one specification
T0 = 12 0.913 0.573 0.875 0.410 0.284 0.033 0.156 0.017
(0.028) (0.043) (0.031) (0.044) (0.030) (0.011) (0.032) (0.008)
T0 = 32 0.963 0.950 0.982 0.906 0.655 0.042 0.066 0.000
(0.026) (0.028) (0.018) (0.032) (0.057) (0.024) (0.030) -
Panel B: # of specifications with good fit
T0 = 12 5.368 2.713 5.000 1.741 1.160 0.093 0.496 0.034
(0.176) (0.233) (0.194) (0.214) (0.135) (0.037) (0.115) (0.018)
T0 = 32 5.771 5.657 5.886 5.279 3.542 0.193 0.303 0.000
(0.160) (0.172) (0.112) (0.202) (0.327) (0.111) (0.143) -
Note: Descriptive statistics are estimated based on six specifications — (1) the mean of all pre-treatment outcome values, (2) all pre-
treatment outcome values, (3) the first half of the pre-treatment outcome values, (4) the first three quarters of the pre-treatment outcome
values, (5) odd pre-treatment outcome values, and (6) even pre-treatment outcome values — and on 5,000 observations for each outcome
variable (employment and log wages), for each sample (men and women) and number of pre-treatment periods (T0 ∈ {12, 32}).Our measure
of goodness of fit is defined by equation (9). We consider two definitions of good fit; R˜2 > 0.80 and R˜2 > 0.95.
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Table 7: Specification searching - CPS simulations
Log wages Employment
Women Men Women Men
5% test 10% test 5% test 10% test 5% test 10% test 5% test 10% test
(1) (2) (3) (4) (5) (6) (7) (8)
Panel A: Unconditional
T0 = 12 0.114*** 0.204*** 0.109*** 0.188*** 0.122*** 0.209*** 0.112*** 0.205***
(0.013) (0.019) (0.012) (0.016) (0.012) (0.016) (0.013) (0.018)
T0 = 32 0.102** 0.184** 0.097* 0.175** 0.092 0.166* 0.100** 0.191***
(0.026) (0.035) (0.026) (0.038) (0.030) (0.039) (0.023) (0.035)
Panel B: Conditional on R˜2 > 0.80
T0 = 12 0.123*** 0.219*** 0.119*** 0.201*** 0.201*** 0.331*** 0.253*** 0.408***
(0.013) (0.019) (0.012) (0.017) (0.023) (0.026) (0.028) (0.029)
T0 = 32 0.104** 0.187** 0.099* 0.178** 0.126* 0.210** 0.151 0.241
(0.027) (0.037) (0.027) (0.038) (0.042) (0.054) (0.080) (0.108)
Panel C: Conditional on R˜2 > 0.95
T0 = 12 0.163*** 0.275*** 0.171*** 0.280*** 0.403*** 0.522*** 0.417*** 0.595***
(0.016) (0.023) (0.017) (0.022) (0.052) (0.045) (0.046) (0.055)
T0 = 32 0.106** 0.189** 0.094* 0.178** 0.185*** 0.379*** - -
(0.027) (0.037) (0.025) (0.037) (0.043) (0.057) - -
Note: Rejection rates are estimated based on six specifications — (1) the mean of all pre-treatment outcome values, (2) all pre-
treatment outcome values, (3) the first half of the pre-treatment outcome values, (4) the first three quarters of the pre-treatment
outcome values, (5) odd pre-treatment outcome values, and (6) even pre-treatment outcome values — and on 5,000 observations
for each outcome variable (employment and log wages), for each sample (men and women) and number of pre-treatment periods
(T0 ∈ {12, 32}). z% test indicates that the nominal size of the analyzed test is z%. Our measure of goodness of fit is defined by
equation (9). We consider two definitions of good fit; R˜2 > 0.80 and R˜2 > 0.95. * means that we reject at 10% the null that
the probability of rejecting at least one specification at z% is equal to z%. ** means that we reject at 5%, while *** means that
we reject at 1%.
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Table 8: Specification searching excluding specification 1 - CPS simulations
Log wages Employment
Women Men Women Men
5% test 10% test 5% test 10% test 5% test 10% test 5% test 10% test
(1) (2) (3) (4) (5) (6) (7) (8)
Panel A: Unconditional
T0 = 12 0.100*** 0.178*** 0.096*** 0.165*** 0.105*** 0.183*** 0.100*** 0.181***
(0.012) (0.018) (0.011) (0.016) (0.011) (0.016) (0.012) (0.017)
T0 = 32 0.079 0.145 0.071 0.135 0.070 0.133 0.077 0.149
(0.022) (0.032) (0.021) (0.033) (0.025) (0.034) (0.019) (0.030)
Panel B: Conditional on R˜2 > 0.80
T0 = 12 0.108*** 0.193*** 0.106*** 0.183*** 0.198*** 0.322*** 0.251*** 0.406***
(0.012) (0.018) (0.011) (0.016) (0.023) (0.026) (0.027) (0.029)
T0 = 32 0.082 0.149 0.072 0.137 0.105 0.185* 0.151 0.241
(0.023) (0.033) (0.021) (0.033) (0.036) (0.049) (0.080) (0.108)
Panel C: Conditional on R˜2 > 0.95
T0 = 12 0.154*** 0.264*** 0.166*** 0.273*** 0.403*** 0.522*** 0.417*** 0.595***
(0.016) (0.022) (0.016) (0.022) (0.052) (0.045) (0.046) (0.055)
T0 = 32 0.083 0.151 0.076 0.142 0.185*** 0.379*** - -
(0.024) (0.033) (0.022) (0.034) (0.043) (0.057) - -
Note: Rejection rates are estimated based on five specifications — (1) all pre-treatment outcome values, (2) the first half of the
pre-treatment outcome values, (3) the first three quarters of the pre-treatment outcome values, (4) odd pre-treatment outcome
values, and (5) even pre-treatment outcome values — and on 5,000 observations for each outcome variable (employment and
log wages), for each sample (men and women) and number of pre-treatment periods (T0 ∈ {12, 32}). z% test indicates that the
nominal size of the analyzed test is z%. Our measure of goodness of fit is defined by equation (9). We consider two definitions
of good fit; R˜2 > 0.80 and R˜2 > 0.95. * means that we reject at 10% the null that the probability of rejecting at least one
specification at z% is equal to z%. ** means that we reject at 5%, while *** means that we reject at 1%.
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Table 9: Specification Searching - Database from Smith (2015)
Equatorial Guinea Ecuador
p-value R˜2 p-value R˜2
(1) (2) (3) (4)
(1a) 0.031 0.828 0.538 0.881
(1b) 0.031 0.744 0.769 0.804
(2a) 0.031 0.848 0.538 0.804
(2b) 0.031 0.657 0.077 0.972
(3a) 0.031 0.866 0.538 0.881
(3b) 0.031 0.797 0.385 0.975
(4a) 0.031 0.809 0.615 0.880
(4b) 0.031 0.790 0.231 0.972
(5a) 0.031 0.777 0.538 0.881
(5b) 0.031 0.832 0.308 0.975
(6a) 0.031 0.891 0.308 0.969
(6b) 0.031 0.536 0.077 0.970
# of Permutations 33 14
Note: We analyze twelve different specifications. The number of the spec-
ifications refer to: (1) even pre-treatment outcome values (original specifi-
cation by Smith (2015)), (2) the mean of all pre-treatment outcome values,
(3) all pre-treatment outcome values, (4) the first half of the pre-treatment
outcome values, (5) the first three quarters of the pre-treatment outcome
values and (6) odd pre-treatment outcome values. Specifications that end
with an a include the covariates ethnic fragmentation and population size
one year before the discovery, while specifications that end with an b do not
include covariates. Our measure of goodness of fit is defined by equation
(9).
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Table 10: Specification Searching - Database from Abadie et al. (2010)
Specification (1a) (1b) (2a) (2b) (3a) (3b) (4a) (4b)
p-value 0.026 0.077 0.077 0.077 0.077 0.077 0.026 0.051
R˜2 0.975 0.909 0.828 0.525 0.979 0.979 0.968 0.969
Specification (5a) (5b) (6a) (6b) (7a) (7b)
p-value 0.077 0.077 0.026 0.051 0.077 0.077
R˜2 0.976 0.974 0.978 0.978 0.979 0.978
Note: We analyze fourteen different specifications. The number of the specifications refer
to: (1) original specification by Abadie et al. (2010)), (2) the mean of all pre-treatment
outcome values, (3) all pre-treatment outcome values, (4) the first half of the pre-treatment
outcome values, (5) the first three quarters of the pre-treatment outcome values, (6) odd
pre-treatment outcome values and (7) even pre-treatment outcome values. Specifications
that end with an a include the covariates average retail price of cigarettes, per capita state
personal income (logged), percentage of the population age 15–24, and per capita beer con-
sumption, while specifications that end with an b do not include covariates. Our measure
of goodness of fit is defined by equation (9).
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ONLINE APPENDIX
(NOT FOR PUBLICATION)
A Model with time-invariant covariates
In Section 3 we provide evidence that specification 1 (pre-treatment outcome mean as eco-
nomic predictor) fails to take into account the time-series dynamics of the data, which implies
that the SC estimator using this specification does not converge to the SC estimators using
the other specifications. As a consequence, the possibilities for specification searching do not
vanish even when the number of pre-treatment periods is large. However, in most applica-
tions that use the pre-treatment outcome mean as economic predictor, other time-invariant
covariates are also considered as economic predictors. Here we consider an alternative MC
simulation where we include time-invariant covariates, and we show that the same pattern
observed in Section 3 can arise even when we consider specifications that also include time-
invariant covariates as economic predictors.
The alternative DGP is given by:
Y 0j,t = δt + λ
k
t + θtZi + jt (10)
where Zi = 1 for i = 1, ..., 10 and Zi = 0 for i = 11, ..., 20. As in our DGP from Section 3, we
consider K = 10.39 We consider that λkt is normally distributed following an AR(1) process
with 0.5 serial correlation parameter, δt ∼ N(0, 1), j,t ∼ N(0, 0.1), and θt ∼ N(0, 1). We
consider the same six specifications as in Section 3, except that we also include Zi as economic
predictor.
In column 1 of Table A.8 we present the proportion of misallocated weights for specification
1. Similarly to our findings in Section 3, specification 1 misallocates significantly more weight
relative to the other specifications, and, importantly, the misallocation of weights remains
constant when T0 increases.
40 In column 2 of Table A.8 we show that our measure of variability
39Therefore, units 1 and 2 follow the trend λ1t , units 3 and 4 follow the trend λ
2
t , and so on.
40The misallocation for the other specifications is similar to the stationary model considered in Section 3.
Results available upon request.
46
of weights also remain constant with T0, which implies that there is still substantial differences
in the SC estimators when we consider different specifications, even when T0 is large. Given
that specification 1 remains very different from the other specification even with large T0, the
possibilities for specification searching remain high for large T0, as presented in columns 3 and
4 of Table A.8. This is similar to our findings in Section 3. The intuition is that including Zi
as an economic predictor helps prevent that the SC estimator will allocate positive weights to
units i = 11, ..., 20. However, this specification still fails to capture the time-series dynamics
when allocating weights among units i = 2, ..., 10.
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B Appendix Tables
Table A.1: Specification searching - Alternative Models
Model (7) with j,t ∼ N(0, 1) Model (7) with K = 2
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
T0 = 12 0.121 0.218 0.124 0.225
(0.004) (0.006) (0.005) (0.006)
T0 = 32 0.122 0.211 0.130 0.229
(0.004) (0.006) (0.005) (0.006)
T0 = 100 0.113 0.208 0.118 0.217
(0.004) (0.006) (0.005) (0.006)
T0 = 400 0.100 0.187 0.113 0.202
(0.004) (0.006) (0.005) (0.006)
Note: Rejection rates are estimated based on 5,000 observations and on six specifi-
cations — (1) the mean of all pre-treatment outcome values, (2) all pre-treatment
outcome values, (3) the first half of the pre-treatment outcome values, (4) the first
three quarters of the pre-treatment outcome values, (5) odd pre-treatment outcome
values, and (6) even pre-treatment outcome values. z% test indicates that the nom-
inal size of the analyzed test is z% and T0 is the number of pre-treatment periods.
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Table A.2: Probability of good pre-treatment fit - Alternative Models
Model (7) with j,t ∼ N(0, 1) Model (7) with K = 2
R˜2 > 0.80 R˜2 > 0.95 R˜2 > 0.80 R˜2 > 0.95
(1) (2) (3) (4)
Panel A: At least one specification with good fit
T0 = 12 0.234 0.005 0.991 0.671
(0.003) (0.001) (0.001) (0.007)
T0 = 32 0.008 0.000 1.000 0.642
(0.003) (0.001) (0.001) (0.007)
T0 = 100 0.000 0.000 1.000 0.493
(0.003) (0.001) (0.001) (0.007)
T0 = 400 0.000 0.000 1.000 0.349
(0.003) (0.001) (0.001) (0.007)
Panel B: # of specifications with good fit
T0 = 12 0.615 0.008 5.606 2.764
(0.010) (0.001) (0.008) (0.031)
T0 = 32 0.018 0.000 5.794 2.636
(0.010) (0.001) (0.008) (0.031)
T0 = 100 0.000 0.000 5.823 1.801
(0.010) (0.001) (0.008) (0.031)
T0 = 400 0.000 0.000 5.801 1.322
(0.010) (0.001) (0.008) (0.031)
Panel C: Specification 1 has a good fit
T0 = 12 0.003 0 0.732 0.098
(0.000) - (0.006) (0.003)
T0 = 32 0.000 0 0.796 0.048
(0.000) - (0.006) (0.003)
T0 = 100 0.000 0 0.823 0.002
(0.000) - (0.006) (0.003)
T0 = 400 0.000 0 0.801 0.000
(0.000) - (0.006) (0.003)
Note: Descriptive statistics are estimated based on 5,000 observations and on the six
specifications defined in Section 3. T0 is the number of pre-treatment periods. Our
measure of goodness of fit is defined by equation (9). We consider two definitions
of good fit; R˜2 > 0.80 and R˜2 > 0.95.
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Table A.3: Specification searching conditional on a good pre-treatment fit - Alter-
native Models
Model (7) with j,t ∼ N(0, 1) Model (7) with K = 2
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
Panel A: R˜2 > 0.80
T0 = 12 0.235 0.379 0.122 0.222
(0.012) (0.014) (0.005) (0.006)
T0 = 32 0.286 0.524 0.125 0.222
(0.066) (0.075) (0.005) (0.006)
T0 = 100 - - 0.113 0.210
- - (0.005) (0.006)
T0 = 400 - - 0.109 0.194
- - (0.005) (0.006)
Panel B: R˜2 > 0.95
T0 = 12 0.808 0.808 0.144 0.256
(0.079) (0.079) (0.006) (0.007)
T0 = 32 - - 0.135 0.229
- - (0.006) (0.007)
T0 = 100 - - 0.103 0.190
- - (0.007) (0.008)
T0 = 400 - - 0.087 0.152
- - (0.008) (0.01)
Note: Rejection rates are estimated based on 5,000 observations and on six specifi-
cations — (1) the mean of all pre-treatment outcome values, (2) all pre-treatment
outcome values, (3) the first half of the pre-treatment outcome values, (4) the first
three quarters of the pre-treatment outcome values, (5) odd pre-treatment outcome
values, and (6) even pre-treatment outcome values. z% test indicates that the nom-
inal size of the analyzed test is z% and T0 is the number of pre-treatment periods.
Our measure of goodness of fit is defined by equation (9). We consider two definitions
of good fit; R˜2 > 0.80 and R˜2 > 0.95.
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Table A.4: Variability and Misallocation of weights - Alternative Models
Misallocation of weights in specification: Variability of weights
1 2 3 4 5 6 All Exclude 1
(1) (2) (3) (4) (5) (6) (7) (8)
Panel A: Model (7) with j,t ∼ N(0, 1)
T0 = 12 0.883 0.703 0.734 0.748 0.719 0.725 0.677 0.554
(0.003) (0.003) (0.004) (0.004) (0.004) (0.004) (0.003) (0.003)
T0 = 32 0.872 0.576 0.571 0.618 0.564 0.570 0.631 0.43
(0.004) (0.002) (0.003) (0.004) (0.003) (0.003) (0.002) (0.002)
T0 = 100 0.878 0.508 0.480 0.531 0.477 0.479 0.605 0.295
(0.003) (0.001) (0.002) (0.002) (0.002) (0.002) (0.002) (0.001)
T0 = 400 0.877 0.472 0.461 0.480 0.462 0.459 0.574 0.170
(0.003) (0.001) (0.001) (0.001) (0.001) (0.001) (0.002) (0.001)
Panel B: Model (7) with K = 2
T0 = 12 0.207 0.044 0.049 0.06 0.048 0.048 0.737 0.586
(0.003) (0.001) (0.001) (0.001) (0.001) (0.001) (0.002) (0.003)
T0 = 32 0.219 0.027 0.029 0.041 0.028 0.029 0.673 0.497
(0.003) (0.000) (0.001) (0.001) (0.001) (0.001) (0.002) (0.002)
T0 = 100 0.204 0.016 0.018 0.025 0.018 0.018 0.612 0.372
(0.003) (0.000) (0.000) (0.001) (0.000) (0.000) (0.003) (0.001)
T0 = 400 0.219 0.008 0.010 0.013 0.010 0.010 0.540 0.217
(0.003) (0.000) (0.000) (0.000) (0.000) (0.000) (0.003) (0.001)
Note: The average of misallocated weights is based on 5,000 observations. The reasoning behind this variable is
the following: since, in our DGP, we divide units into groups whose trends are parallel only when compared to
units in the same group, the sum of the weights allocated to the units in the other groups is a measure of the
relevance given by the synthetic control method to units whose true potential outcome follows a different trajectory
than the one followed by the unit chosen to be the treated one. The average of variability of weights is based
on 5,000 observations and captures the average maximum difference of allocated weights across specifications.
Specification s is one of the specifications used to compute the synthetic control unit: (1) the mean of all pre-
treatment outcome values, (2) all pre-treatment outcome values, (3) the first half of the pre-treatment outcome
values, (4) the first three quarters of the pre-treatment outcome values, (5) odd pre-treatment outcome values,
and (6) even pre-treatment outcome values. T0 is the number of pre-treatment periods.
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Table A.5: Specification searching - Excluding specification 1 - Alternative Models
Model (7) with j,t ∼ N(0, 1) Model (7) with K = 2
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
Panel A: Unconditional
T0 = 12 0.102 0.186 0.098 0.186
(0.004) (0.005) (0.004) (0.005)
T0 = 32 0.106 0.184 0.104 0.186
(0.004) (0.005) (0.004) (0.005)
T0 = 100 0.092 0.172 0.09 0.172
(0.004) (0.005) (0.004) (0.005)
T0 = 400 0.079 0.148 0.081 0.148
(0.004) (0.005) (0.004) (0.005)
Panel B: Conditional on R˜2 > 0.80
T0 = 12 0.234 0.377 0.099 0.187
(0.012) (0.014) (0.004) (0.005)
T0 = 32 0.286 0.524 0.104 0.186
(0.066) (0.075) (0.004) (0.005)
T0 = 100 - - 0.09 0.172
- - (0.004) (0.005)
T0 = 400 - - 0.081 0.148
- - (0.004) (0.005)
Panel C: Conditional on R˜2 > 0.95
T0 = 12 0.808 0.808 0.133 0.243
(0.079) (0.079) (0.006) (0.007)
T0 = 32 - - 0.13 0.223
- - (0.006) (0.007)
T0 = 100 - - 0.103 0.190
- - (0.006) (0.008)
T0 = 400 - - 0.087 0.152
- - (0.008) (0.010)
Note: Rejection rates are estimated based on 5,000 observations and on specifications
(2)-(6), defined in Section 3. z% test indicates that the nominal size of the analyzed
test is z% and T0 is the number of pre-treatment periods.Our measure of goodness
of fit is defined by equation (9). We consider two definitions of good fit; R˜2 > 0.80
and R˜2 > 0.95.
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Table A.6: Specification searching - Excluding specification 2
Stationary Model Non-stationary Model
5% test 10% test 5% test 10% test
(1) (2) (3) (4)
Panel A: Unconditional
T0 = 12 0.125 0.222 0.122 0.218
(0.005) (0.006) (0.005) (0.006)
T0 = 32 0.126 0.231 0.135 0.239
(0.005) (0.006) (0.005) (0.006)
T0 = 100 0.121 0.220 0.128 0.233
(0.005) (0.006) (0.005) (0.006)
T0 = 400 0.114 0.211 0.117 0.213
(0.005) (0.006) (0.005) (0.006)
Panel B: Conditional on R˜2 > 0.80
T0 = 12 0.103 0.185 0.109 0.190
(0.004) (0.005) (0.005) (0.006)
T0 = 32 0.098 0.178 0.117 0.203
(0.004) (0.005) (0.005) (0.006)
T0 = 100 0.089 0.154 0.122 0.219
(0.004) (0.005) (0.005) (0.006)
T0 = 400 0.079 0.142 0.117 0.213
(0.004) (0.005) (0.005) (0.006)
Panel C: Conditional on R˜2 > 0.95
T0 = 12 0.208 0.336 0.121 0.210
(0.012) (0.014) (0.006) (0.007)
T0 = 32 0.188 0.328 0.110 0.189
(0.020) (0.024) (0.005) (0.006)
T0 = 100 0.286 0.429 0.101 0.176
(0.152) (0.178) (0.004) (0.006)
T0 = 400 - - 0.106 0.189
- - (0.004) (0.006)
Note: Rejection rates are estimated based on 5,000 observations and on
specifications (1) and (3)-(6), defined on Section 3. z% test indicates
that the nominal size of the analyzed test is z% and T0 is the number
of pre-treatment periods. Our measure of goodness of fit is defined by
equation (9). We consider two definitions of good fit; R˜2 > 0.80 and
R˜2 > 0.95.
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Table A.7: Specification searching excluding specification 2 - CPS simulations
Log wages Employment
Women Men Women Men
5% test 10% test 5% test 10% test 5% test 10% test 5% test 10% test
(1) (2) (3) (4) (5) (6) (7) (8)
Panel A: Unconditional
T0 = 12 0.110*** 0.198*** 0.106*** 0.184*** 0.119*** 0.205*** 0.110*** 0.199***
(0.012) (0.018) (0.011) (0.016) (0.011) (0.016) (0.013) (0.017)
T0 = 32 0.101** 0.183** 0.096* 0.173* 0.092 0.166* 0.099** 0.190**
(0.025) (0.035) (0.026) (0.037) (0.030) (0.039) (0.023) (0.035)
Panel B: Conditional on R˜2 > 0.80
T0 = 12 0.120*** 0.213*** 0.116*** 0.198*** 0.201*** 0.329*** 0.256*** 0.407***
(0.012) (0.018) (0.012) (0.016) (0.023) (0.025) (0.027) (0.028)
T0 = 32 0.103** 0.186** 0.098* 0.176** 0.126* 0.210** 0.151 0.246
(0.026) (0.036) (0.027) (0.038) (0.042) (0.054) (0.082) (0.109)
Panel C: Conditional on R˜2 > 0.95
T0 = 12 0.163*** 0.274*** 0.173*** 0.283*** 0.431*** 0.528*** 0.409*** 0.545***
(0.015) (0.022) (0.016) (0.021) (0.070) (0.059) (0.066) (0.058)
T0 = 32 0.105** 0.188** 0.094* 0.176** 0.188*** 0.375*** - -
(0.027) (0.037) (0.025) (0.037) (0.043) (0.056) - -
Note: Rejection rates are estimated based on five specifications — (1) the mean of all pre-treatment outcome values, (2) the
first half of the pre-treatment outcome values, (3) the first three quarters of the pre-treatment outcome values, (4) odd pre-
treatment outcome values, and (5) even pre-treatment outcome values — and on 5,000 observations for each outcome variable
(employment and log wages), for each sample (men and women) and number of pre-treatment periods (T0 ∈ {12, 32}). z%
test indicates that the nominal size of the analyzed test is z%. Our measure of goodness of fit is defined by equation (9). We
consider two definitions of good fit; R˜2 > 0.80 and R˜2 > 0.95. * means that we reject at 10% the null that the probability of
rejecting at least one specification at z% is equal to z%. ** means that we reject at 5%, while *** means that we reject at 1%.
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Table A.8: Model with time-invariant covariates
Misallocation Variability Specification Searching
of Weights of Weights 5% test 10% test
(1) (2) (3) (4)
T0 = 12 0.624 0.611 0.126 0.230
(0.005) (0.004) (0.005) (0.006)
T0 = 32 0.615 0.599 0.123 0.224
(0.005) (0.004) (0.005) (0.006)
T0 = 100 0.613 0.593 0.121 0.212
(0.005) (0.005) (0.005) (0.006)
T0 = 400 0.609 0.578 0.108 0.197
(0.005) (0.005) (0.005) (0.006)
Note: This table presents results based on 5,000 observations of the MC simulations
described in Appendix A. Column 1 presents the misallocation of weights for spec-
ification 1 (pre-treatment outcome mean and Zi as economic predictors). Column
2 presents the variability of weights considering all six specifications including Zi as
economic predictor. Columns (3) and (4) present the probability of rejecting the null
in at least one specification at, respectively, 5% and 10% significance level.
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